IASLC thoracic oncology

Description

Front Cover; IFC; IASLC Thoracic Oncology; IASLC Thoracic Oncology; Copyright; Contributors; Preface; Contents; I -- Lung Cancer Control and Epidemiology; 1 -- Classic Epidemiology of Lung Cancer; DESCRIPTIVE EPIDEMIOLOGY; RISK FACTORS; Tobacco Smoking; Differences in the Effect of Tobacco Smoking According to Histology, Gender, and Race; Secondhand Tobacco Smoke; Confounding Effects of Tobacco Smoking; Interaction Between Tobacco Smoke and Other Lung Carcinogens; Use of Smokeless Tobacco Products; Dietary Factors; Vegetables and Fruits; Meat and Other Foods; Coffee and Tea; Lipids; Carotenoids. Front Cover IFC IASLC Thoracic Oncology IASLC Thoracic Oncology Copyright Contributors Preface Contents I -- Lung Cancer Control and Epidemiology 1 -- Classic Epidemiology of Lung Cancer DESCRIPTIVE EPIDEMIOLOGY RISK FACTORS Tobacco Smoking Differences in the Effect of Tobacco Smoking According to Histology, Gender, and Race Secondhand Tobacco Smoke Confounding Effects of Tobacco Smoking Interaction Between Tobacco Smoke and Other Lung Carcinogens Use of Smokeless Tobacco Products Dietary Factors Vegetables and Fruits Meat and Other Foods Coffee and Tea Lipids Carotenoids. Other MicronutrientsIsothiocyanates Alcohol Hormones Anthropometric Measures Infections Ionizing Radiation Occupational Exposures Asbestos Metals Silica Polycyclic Aromatic Hydrocarbons Medical Conditions and Treatment Indoor Air Pollution Outdoor Air Pollution Drinking Water Contamination CONCLUSION KEY REFERENCES REFERENCES 2 -- Tobacco Control and Primary Prevention HISTORICAL CONTEXT OF THE TOBACCO EPIDEMIC 21ST CENTURY TOBACCO-CONTROL MEASURES Monitor Tobacco Use and Prevention Policies Protect People From Tobacco Smoke Offer Help to Quit Tobacco Use. Warn About the Dangers of TobaccoEnforce Bans on Tobacco Advertising, Promotion, and Sponsorship Raise Taxes on Tobacco Combinations of Measures Impact of Tobacco Control on Lung Cancer Mortality CONCLUSION KEY REFERENCES REFERENCES 3 -- Assessing and Treating Tobacco Use in Lung Cancer Care WHY LUNG CANCER SPECIALISTS SHOULD HELP THEIR PATIENTS STOP TOBACCO USE Risks of Persistent Smoking and Benefits of Cessation on Lung Cancer Outcomes Prevalence of Persistent Smoking Among Patients With Lung Cancer FACTORS ASSOCIATED WITH PERSISTENT SMOKING AMONG PATIENTS WITH LUNG CANCER. ASSESSING TOBACCO USE AND INTEGRATING EVIDENCE-BASED TOBACCO TREATMENT IS AN INDICATOR OF HIGH-QUALITY ONCOLOGY CARETREATMENT OF TOBACCO DEPENDENCE IN LUNG CANCER CARE Guidelines for Treating Tobacco Use Pharmacotherapy SPECIAL CONSIDERATIONS IN TREATING TOBACCO DEPENDENCE IN PATIENTS WITH CANCER FUTURE DIRECTIONS CONCLUSION KEY REFERENCES REFERENCES 4 -- Lung Cancer in Never-Smokers: A Different Disease EPIDEMIOLOGY OF NONSMOKING-RELATED LUNG CANCER KNOWN OR SUSPECTED ETIOLOGIC FACTORS FOR LUNG CANCER IN NEVER-SMOKERS Indoor Air Pollution Environmental and Occupational Toxins. Human PapillomavirusCLINICAL-PATHOLOGIC FEATURES OF LUNG CANCER IN NEVER-SMOKERS THE GENETICS OF LUNG CANCER MOLECULAR CHARACTERISTICS OF NONSMOKING EAST ASIAN INDIVIDUALS WITH LUNG CANCER GENOME-WIDE MOLECULAR CHANGES PRENEOPLASTIC CHANGES DNA METHYLATION CONCLUSION KEY REFERENCES REFERENCES 5 -- Gender-Related Differences in Lung Cancer EPIDEMIOLOGY United States Europe Asia SUSCEPTIBILITY Never-Smokers Smokers GENETIC FACTORS FAMILY HISTORY VIRAL FACTORS ENVIRONMENTAL EXPOSURES, DIET, AND PREEXISTING LUNG DISEASE Environmental Exposures Diet Preexisting Lung Disease.